U.S. FDA Warning Letters To Foreign Manufacturing Facilities Rise Dramatically
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA's device center is sending a record number of warning letters to foreign facilities as the agency continues its efforts to more effectively oversee product manufacturing located outside the U.S